Loading…
Moving From Political Declaration to Action on Reducing the Global Burden of Cardiovascular Diseases
[...]in 2013, this target, as well as 8 additional targets addressing modifiable risk factors and committing to the use of essential medicines, technologies, and drug therapies to prevent heart attacks and strokes, have been adopted as part of a global monitoring framework and included in the World...
Saved in:
Published in: | Journal of the American College of Cardiology 2013-12, Vol.62 (22), p.2151-2153 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]in 2013, this target, as well as 8 additional targets addressing modifiable risk factors and committing to the use of essential medicines, technologies, and drug therapies to prevent heart attacks and strokes, have been adopted as part of a global monitoring framework and included in the World Health Organization's Global Action Plan for the Prevention and Control of NCDs (see Online-Only Appendix for a list of the globally agreed targets and indicators) (4,5). Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Sidney C. Smith, Jr University of North Carolina, Chapel Hill None None None None None None None Deborah Chen The Heart Foundation of Jamaica None None None None None None None Amy Collins World Heart Federation None None None None None None None John G. Harold Self-employed None None None None None None None Mariell Jessup University of Pennsylvania None None None None None None None Staffan Josephson The Swedish Heart & Lung Foundation None None None None None None None Susanne Logstrup European Heart Network None None None None None None None Ralph L. Sacco University of Miami None None None None None None None Panos E. Vardas Heraklion University Hospital, Greece None None Bayer[dagger]; Servier[low *];BoehringerIngelheim[low *];Menarini[low *]; Pfizer[low *] None None Respicardia[low *] None David A. Wood Imperial College London None None AstraZeneca[low *]; Kowa[low *]; MSD[low *] None None MSD[low *] None William A. Zoghbi Houston Methodist Hospital None None None None None None None [low *] Writing Group Disclosures This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2013.08.722 |